Naloxone

OpioidsJul 31, 2020

Nation’s drug overdose epidemic requires new policy focus

The nation’s overdose epidemic is being increasingly fueled by illicitly manufactured fentanyl, psychostimulants, heroin, cocaine and drug combinations.

AMA StatementsJul 23, 2020

AMA applauds FDA for requiring naloxone information on opioid labels

The new labeling can serve as a starting point for discussion between patients and physicians about risks and benefits associated with opioids.

Press ReleasesJul 20, 2020

AMA report shows evolving, deadlier overdose epidemic

AMA cites need to remove barriers to evidence-based care for patients with pain or a substance use disorder.

OpioidsJun 23, 2020

How to reignite the fight against the nation’s opioid epidemic

The COVID-19 crisis is far from over, yet the opioid epidemic continues to flare. The AMA details steps states should take, and calls on CDC to revise its opioid prescribing guideline.

Public HealthJun 4, 2020

In COVID-19 crisis, AMA’s powerful voice rings out to save lives

Learn about the AMA’s effective advocacy on critical issues such as access to PPE, telehealth, financial relief for doctors, health care inequities, and more.

OpioidsMay 29, 2020

AMA COVID-19 daily video update: Experts discuss the pandemic’s impact on the opioid epidemic

The AMA is leading the fight against the COVID-19 pandemic. See the latest daily video update on how the COVID-19 pandemic has impacted the opioid epidemic.

OpioidsMay 28, 2020

COVID-19 may be worsening opioid crisis, but states can take action

The pandemic is exacerbating the ongoing opioid epidemic. The AMA is calling on states to take specific steps to save lives, reduce harm and get patients treatment they need.

OpioidsApr 14, 2020

Taking action on opioid use disorder, pain & harm reduction during COVID-19

Policy recommendations focused on pain, opioid use disorder (OUD) and harm reduction to help states during the COVID-19 epidemic.

Membership Moves Medicine™

Free access to JAMA Network™ and CME
Save hundreds on insurance
Fight for physicians and patient rights

Join the AMA today

Behavioral health integration webinar series: Value of collaboration & culture

AMA COVID-19 daily video update: Get the latest on vaccines that have entered phase 3 trials

COVID-19 response spurs rapid development of 2 new CPT codes

Congress plays name game to redefine “physician” under Medicare

COVID-19 shows why health systems science matters so much

Amid COVID-19 crisis, tips for medical schools from corporate America

Pandemic brings new expectations for medical students’ behavior

USMLE Step 3: Test yourself against our all-time top stumpers

Ruling threatens essential physician attorney-client privilege

AMA: Insurers misused CPT codes to hide administrative costs

AMA membership dues

Auto & transportation discounts

Business of the November 2020 Special Meeting of the AMA House of Delegates

HOD speakers' info, reference committee service and reports for member input

Medical education leadership opportunities

About the Council on Long Range Planning & Development (CLRPD)

WPS November 2020 Meeting agenda & resources

YPS November 2020 Meeting agenda & resources

Top news stories from AMA Morning Rounds®: Week of Sept. 21, 2020

Despite advances, gender disparities persist in medicine